99%Epitalon CAS 307297-39-8 Epithalon peptide Epithalone Powder Epithalon Acetate TB500 SK AOD IPA AR
TDS 52 Inquiries
307297-39-8
Pharmaceutical Grade
99.87%
hongkong
Customization Available
10mg*10vials/box,50mg*10vials/box,
2026-08-23
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Product Description
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceEpitalon is an anti-aging agent and a telomerase activator. Epitalon has an inhibitory effect of the on the development of spontaneous tumors in mice, has geroprotective actions and intranasal administration increases neuronal activity. Epitalon can be used for cancer, old age and Retinitis Pigmentosa[1].Certificates
-
TDS
Basic Info-
Product Name:
Epitalon
Other Name:AE-0 peptide;Ala-Glu-Asp-Gly;alanyl-glutamyl-aspartyl-glycine;epitalon;epithalon;epithalone;307297-39-8;UNII-O65P17785G
CAS No.:307297-39-8
Molecular Formula:C14H22N4O9
InChIKeys:HGHOBRRUMWJWCU-FXQIFTODSA-N
Molecular Weight:390.346
Exact Mass:390.138672
Categories:
Characteristics-
PSA:
225
XLogP3:-2.02
Density:1.5±0.1 g/cm3
Boiling Point:959.8±65.0 °C at 760 mmHg
Flash Point:534.3±34.3 °C
Refractive Index:1.559
Research-
Class:
Actin-sequestering protein / 43-amino-acid peptide
Status:Research compound — Not FDA approved (investigational: RGN-259 for dry eye / neurotrophic keratitis)
Mechanism:A naturally occurring 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) that binds G-actin (sequesters monomeric actin), preventing F-actin polymerization. Promotes cell migration, angiogenesis, wound healing, and anti-inflammatory responses via integrin-linked kinase (ILK) and HIF-1α/VEGF pathways. TB-500 is the synthetic fragment Ac-LKKTETQ (MW ~895) often sold under this CAS.
Activity note:Thymosin Beta-4 is an actin-binding protein, not a receptor agonist. Functional activity is measured by actin sequestration (Kd ~0.7–1 μM) and cell migration assays, not EC₅₀.
Source:Goldstein AL, et al. Vitam Horm. 2003;66:257–296. RegeneRx RGN-259 clinical program.DOI
Clinical Development:
References-
DrugBank:PubChem:UNII:Disclaimer:
Thymosin Beta-4 (TB-500) is NOT FDA-approved for human therapeutic use. RGN-259 (Tβ4 ophthalmic solution) is an investigational drug not yet approved. TB-500 sold on research-chemical marketplaces is a synthetic fragment and is not an approved medicine. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Location:
Room 11B, Building 0056, No. 81-1 Nonglinxia Road, Yuexiu District, Guangzhou City, Guangdong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History52 Inquiries
Country Product Purchase Quantity Date Posted
United States
N-Acetyl Epitalon Amidate CAS 307297-39-8 Epitalon 99% White Powder 99% N-Acetyl Epitalon Amidate
1 Oct 4, 2023
United States
N-Acetyl Epitalon Amidate CAS 307297-39-8 Epitalon 99% White Powder 99% N-Acetyl Epitalon Amidate
1 G Oct 7, 2023
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026
United States
epithalon
10 MG Jun 3, 2026
United States
Epitalon
10 MT May 14, 2026
United Kingdom
Epitalon
50 MT Apr 22, 2026
Australia
Epithalon
2 G Apr 3, 2026
United States
Epithalon
500 MG Mar 25, 2026
Australia
Epithalon
30 MG Mar 19, 2026
United Kingdom
Epitalon
200 MG Mar 18, 2026
United States
Epitalon
50 MT Mar 16, 2026
United States
Epitalon
1 PCS Mar 10, 2026
India
Epitalon
1 KG Feb 26, 2026
United States
Epitalon (CAS 307297-39-8) and Pinealon (CAS 175175-23-2) - ORAL CAPSULE Form Only
1000 PCS Feb 4, 2026
United States
Epitalon & Pinealon Peptides - Oral Capsule Form
10 G Feb 3, 2026
United States
Epithalon
10 Jan 6, 2026
United States
Epitalon
2 G Jan 6, 2026
United States
Epitalon
5 MT Jul 19, 2025
United States
Epithalon
10 MT Apr 2, 2025
South Korea
epitalon
1 G Feb 22, 2025 Post an enquiry for this product